Health Care
(E99)
IRS Verified
DX Registered
990 on File
ZERO PROSTATE CANCER
Financial strength (30%)
77/100
Reliability (20%)
55/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
ZERO Prostate Cancer is the leading national nonprofit with the mission to end prostate cancer and help all who are impacted. ZERO advances research, provides support, and creates solutions to achieve health equity to meet the most critical needs of our community.
Financial Overview — FY 2025
$10.4M
Total Revenue
$10.8M
Total Expenses
$6.9M
Net Assets
76
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
71.2%
Fundraising Efficiency
29909.7%
Operating Reserve
7.61x
Liability-to-Asset
12.6%
Revenue Diversification
100.1%
Executive Compensation
$1.1M
Compared with Peers
FY 2025
Compared with 1,090 similar organizations
(United States, Health Care, $10M–$100M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
71.2% | 85.0% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
12.3% | 14.0% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
16.5% | 0.0% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
29909.7% | 299.7% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
7.6 mo | 7.3 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
12.6% | 31.3% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
100.1% | 89.7% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
8.9% | 7.5% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
7.3% | 6.4% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-4.4% | 2.5% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $10.4M | $10.8M | $6.9M | 71.2% | 76 |
| 2024 | $9.5M | $10.1M | $6.4M | 73.2% | 74 |
| 2023 | $9.4M | $10.4M | $5.9M | 85.7% | 76 |
| 2022 | $10.1M | $7.4M | N/A | — | 64 |
| 2021 | $6.8M | $5.0M | N/A | — | 47 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.